Publications

Found 313 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is C  [Clear All Filters]
2023
Maayan O, Lavieri METusa, Babu C, Chua J, Christos PJ, Schwartz TH.  2023.  Additive risk of surgical site infection from more than one risk factor following craniotomy for tumor.. J Neurooncol. 162(2):337-342.
Maayan O, Lavieri METusa, Babu C, Chua J, Christos PJ, Schwartz TH.  2023.  Additive risk of surgical site infection from more than one risk factor following craniotomy for tumor.. J Neurooncol. 162(2):337-342.
Ebani EJ, Strauss S, Thomas C, RoyChoudhury A, Kaplitt MG, J Chazen L.  2023.  Cranial MRgFUS intraprocedural diffusion and T2 imaging and comparison with postablation lesion size and location.. J Neurosurg. :1-5.
Han RK, Chae JK, Garton ALA, Cruz A, Navarro-Ramirez R, Hussain I, Härtl R, Greenfield JP.  2023.  Intraoperative occipital to C2 angle and external acoustic meatus-to-axis angular measurements for optimizing alignment during posterior fossa decompression and occipitocervical fusion for complex Chiari malformation.. J Craniovertebr Junction Spine. 14(4):365-372.
Han RK, Chae JK, Garton ALA, Cruz A, Navarro-Ramirez R, Hussain I, Härtl R, Greenfield JP.  2023.  Intraoperative occipital to C2 angle and external acoustic meatus-to-axis angular measurements for optimizing alignment during posterior fossa decompression and occipitocervical fusion for complex Chiari malformation.. J Craniovertebr Junction Spine. 14(4):365-372.
Bander ED, Carnevale JA, Tosi U, Godfrey KJ, Schwartz TH.  2023.  Lateral Transorbital Endoscope-Assisted Approach to the Cavernous Sinus.. Oper Neurosurg (Hagerstown). 25(4):359-364.
Nassiri F, Patil V, Yefet LS, Singh O, Liu J, Dang RMA, Yamaguchi TN, Daras M, Cloughesy TF, Colman H et al..  2023.  Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.. Nat Med.
Nassiri F, Patil V, Yefet LS, Singh O, Liu J, Dang RMA, Yamaguchi TN, Daras M, Cloughesy TF, Colman H et al..  2023.  Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.. Nat Med.
Nassiri F, Patil V, Yefet LS, Singh O, Liu J, Dang RMA, Yamaguchi TN, Daras M, Cloughesy TF, Colman H et al..  2023.  Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.. Nat Med.
Bander ED, Kelly A, Ma X, Christos PJ, A Wernicke G, Stieg PE, Trichter S, Knisely JPS, Ramakrishna R, Schwartz TH.  2023.  Safety and efficacy of Cesium-131 brachytherapy for brain tumors.. J Neurooncol. 163(2):355-365.
Krishna V, Fishman PS, Eisenberg HM, Kaplitt M, Baltuch G, Chang JWoo, Chang W-C, Fernandez RMartinez, Del Alamo M, Halpern CH et al..  2023.  Trial of Globus Pallidus Focused Ultrasound Ablation in Parkinson's Disease.. N Engl J Med. 388(8):683-693.
Krishna V, Fishman PS, Eisenberg HM, Kaplitt M, Baltuch G, Chang JWoo, Chang W-C, Fernandez RMartinez, Del Alamo M, Halpern CH et al..  2023.  Trial of Globus Pallidus Focused Ultrasound Ablation in Parkinson's Disease.. N Engl J Med. 388(8):683-693.
Krishna V, Fishman PS, Eisenberg HM, Kaplitt M, Baltuch G, Chang JWoo, Chang W-C, Fernandez RMartinez, Del Alamo M, Halpern CH et al..  2023.  Trial of Globus Pallidus Focused Ultrasound Ablation in Parkinson's Disease.. N Engl J Med. 388(8):683-693.
Krishna V, Fishman PS, Eisenberg HM, Kaplitt M, Baltuch G, Chang JWoo, Chang W-C, Fernandez RMartinez, Del Alamo M, Halpern CH et al..  2023.  Trial of Globus Pallidus Focused Ultrasound Ablation in Parkinson's Disease.. N Engl J Med. 388(8):683-693.
2022
Maayan O, Babu C, Lavieri METusa, Chua J, Christos PJ, Schwartz TH.  2022.  Combined use of vancomycin powder and betadine irrigation lowers the incidence of postcraniotomy wound infection in low-risk cases: a single-center risk-stratified cohort analysis.. Acta Neurochir (Wien).
Maayan O, Babu C, Lavieri METusa, Chua J, Christos PJ, Schwartz TH.  2022.  Combined use of vancomycin powder and betadine irrigation lowers the incidence of postcraniotomy wound infection in low-risk cases: a single-center risk-stratified cohort analysis.. Acta Neurochir (Wien).
Giantini-Larsen AM, Garton ALA, Villamater FN, Kuzan-Fischer CM, Savage NJ, Cunniff CM, M Ross E, Christos PJ, Stieg PE, Souweidane MM.  2022.  Familial colloid cysts: not a chance occurrence.. J Neurooncol.
Giantini-Larsen AM, Garton ALA, Villamater FN, Kuzan-Fischer CM, Savage NJ, Cunniff CM, M Ross E, Christos PJ, Stieg PE, Souweidane MM.  2022.  Familial colloid cysts: not a chance occurrence.. J Neurooncol.
Morana G, Shaw D, MacDonald SM, Alapetite C, Ajithkumar T, Bhatia A, Brisse H, Jaimes C, Czech T, Dhall G et al..  2022.  Imaging response assessment for CNS germ cell tumours: consensus recommendations from the European Society for Paediatric Oncology Brain Tumour Group and North American Children's Oncology Group. Lancet Oncol. 23(5):e218-e228.
Morana G, Shaw D, MacDonald SM, Alapetite C, Ajithkumar T, Bhatia A, Brisse H, Jaimes C, Czech T, Dhall G et al..  2022.  Imaging response assessment for CNS germ cell tumours: consensus recommendations from the European Society for Paediatric Oncology Brain Tumour Group and North American Children's Oncology Group. Lancet Oncol. 23(5):e218-e228.
Xie L, Cen L-P, Li Y, Gilbert H-Y, Strelko O, Berlinicke C, Stavarache MA, Ma M, Wang Y, Cui Q et al..  2022.  Monocyte-derived SDF1 supports optic nerve regeneration and alters retinal ganglion cells' response to Pten deletion.. Proc Natl Acad Sci U S A. 119(15):e2113751119.